Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Andrea I Ciplea"'
Autor:
Annika Anderson, William Rowles, Shane Poole, Ayushi Balan, Carolyn Bevan, Rachel Brandstadter, Andrea I. Ciplea, Joanna Cooper, Michelle Fabian, Thomas W. Hale, Dina Jacobs, Mihir Kakara, Kristen M. Krysko, Erin E. Longbrake, Jacqueline Marcus, Pavle Repovic, Claire S. Riley, Andrew R. Romeo, Alice Rutatangwa, Timothy West, Kerstin Hellwig, Sara C. LaHue, Riley Bove
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 11, Pp 2053-2064 (2023)
Abstract Objective Postpartum, patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) have increased risk for disease activity. Anti‐CD20 IgG1 monoclonal antibodies (mAb) are increasingly used as disease‐modifyin
Externí odkaz:
https://doaj.org/article/5711916b3a49420fb8c37e9ca7013cec
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Objectives: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) predominantly affect women of reproductive age. During the last few decades many disease-modifying therapies (DMTs) have been approved. It is therefore important
Externí odkaz:
https://doaj.org/article/2e5a9530b97b474b8b53325b5eeac27f
Publikováno v:
DNP – Die Neurologie & Psychiatrie. 24:30-37
Autor:
Kristen M Krysko, Ruth Dobson, Raed Alroughani, Maria Pia Amato, Riley Bove, Andrea I Ciplea, Yara Fragoso, Maria Houtchens, Vilija G Jokubaitis, Melinda Magyari, Azza Abdelnasser, Vasantha Padma, Sandra Thiel, Mar Tintore, Sandra Vukusic, Kerstin Hellwig
Publikováno v:
The Lancet Neurology. 22:350-366
Autor:
Andrea I. Ciplea, Palika Datta, Kathleen Rewers-Felkins, Teresa Baker, Ralf Gold, Thomas W. Hale, Kerstin Hellwig
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Dimethyl fumarate (DMF) is approved for the treatment of relapsing-remitting multiple sclerosis. It is unknown whether DMF or its primary metabolite monomethyl fumarate (MMF) are excreted into human milk. We present two cases of lactating patients wh
Externí odkaz:
https://doaj.org/article/bc3e6caeb06a4eecb7e06e368107e912
Autor:
Ayse Altintas, Justina Dargvainiene, Christiane Schneider-Gold, Nasrin Asgari, Ilya Ayzenberg, Andrea I. Ciplea, Ralf Junker, Frank Leypoldt, Klaus-Peter Wandinger, Kerstin Hellwig
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are antibody-mediated neurological diseases. They have mostly female predominance, affecting many women
Externí odkaz:
https://doaj.org/article/62c859dd74bc48eea54d485bd5f9ff98
Publikováno v:
Deutsches Ärzteblatt Online.
Publikováno v:
Multiple Sclerosis and Related Disorders. 75:104771
Autor:
Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Spalmai Hemat, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette M. Langer-Gould
Publikováno v:
Neurology - Neuroimmunology Neuroinflammation. 10:e200110
Background and ObjectiveDiscontinuation of fingolimod ≥2 months before pregnancy is recommended to minimize potential teratogenicity. The magnitude of MS pregnancy relapse risk, particularly severe relapses, after fingolimod cessation is unclear, a
Autor:
Kerstin Hellwig, Marianne Tokic, Sandra Thiel, Nina Esters, Charlotte Spicher, Nina Timmesfeld, Andrea I. Ciplea, Ralf Gold, Annette Langer-Gould
Publikováno v:
JAMA Network Open
Key Points Question Is early natalizumab cessation before or during the first trimester of pregnancy associated with multiple sclerosis relapse occurrence and relapse-related disability? Findings In this cohort study of 274 pregnancies, relapses duri